These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 39079344

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
    Jørgensen TN, Thurman J, Izui S, Falta MT, Metzger TE, Flannery SA, Kappler J, Marrack P, Kotzin BL.
    Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
    [Abstract] [Full Text] [Related]

  • 23. Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.
    Lourenço EV, Wong M, Hahn BH, Palma-Diaz MF, Skaggs BJ.
    Arthritis Rheumatol; 2014 Mar; 66(3):674-85. PubMed ID: 24574228
    [Abstract] [Full Text] [Related]

  • 24. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.
    Liu Z, Bethunaickan R, Huang W, Lodhi U, Solano I, Madaio MP, Davidson A.
    Arthritis Rheum; 2011 Jan; 63(1):219-29. PubMed ID: 20954185
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in naïve mice.
    Ben-Ami Shor D, Blank M, Reuter S, Matthias T, Beiglass I, Volkov A, Barshack I, Shoenfeld Y.
    J Autoimmun; 2014 Nov; 54():118-26. PubMed ID: 24662148
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Impact of common epidermal growth factor receptor and HER2 variants on receptor activity and inhibition by lapatinib.
    Gilmer TM, Cable L, Alligood K, Rusnak D, Spehar G, Gallagher KT, Woldu E, Carter HL, Truesdale AT, Shewchuk L, Wood ER.
    Cancer Res; 2008 Jan 15; 68(2):571-9. PubMed ID: 18199554
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like Fibrosis.
    Gardet A, Chou WC, Reynolds TL, Velez DB, Fu K, Czerkowicz JM, Bajko J, Ranger AM, Allaire N, Kerns HM, Ryan S, Legault HM, Dunstan RW, Lafyatis R, Lukashev M, Viney JL, Browning JL, Rabah D.
    PLoS One; 2016 Jan 15; 11(10):e0164423. PubMed ID: 27760209
    [Abstract] [Full Text] [Related]

  • 35. Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.
    Awasthi S, Hamburger AW.
    J Cell Physiol; 2014 Nov 15; 229(11):1831-41. PubMed ID: 24692179
    [Abstract] [Full Text] [Related]

  • 36. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
    Sitrin J, Suto E, Wuster A, Eastham-Anderson J, Kim JM, Austin CD, Lee WP, Behrens TW.
    J Immunol; 2017 Aug 15; 199(4):1238-1249. PubMed ID: 28696253
    [Abstract] [Full Text] [Related]

  • 37. Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model.
    Diaz R, Nguewa PA, Parrondo R, Perez-Stable C, Manrique I, Redrado M, Catena R, Collantes M, Peñuelas I, Díaz-González JA, Calvo A.
    BMC Cancer; 2010 May 11; 10():188. PubMed ID: 20459769
    [Abstract] [Full Text] [Related]

  • 38. Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB × NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells.
    Wang X, Oates JC, Helke KL, Gilkeson GS, Zhang XK.
    Arthritis Rheumatol; 2021 Aug 11; 73(8):1478-1488. PubMed ID: 33559345
    [Abstract] [Full Text] [Related]

  • 39. TLR4+CXCR4+ plasma cells drive nephritis development in systemic lupus erythematosus.
    Ma K, Li J, Wang X, Lin X, Du W, Yang X, Mou F, Fang Y, Zhao Y, Hong X, Chan KW, Zhang X, Liu D, Sun L, Lu L.
    Ann Rheum Dis; 2018 Oct 11; 77(10):1498-1506. PubMed ID: 29925508
    [Abstract] [Full Text] [Related]

  • 40. HSPB5 suppresses renal inflammation and protects lupus-prone NZB/W F1 mice from severe renal damage.
    Knapp J, Braunstein M, Berg SIT, Shirriff C.
    Arthritis Res Ther; 2022 Dec 12; 24(1):267. PubMed ID: 36510250
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.